Valuation: Olympus Corporation

Market Cap 1,851B 11.75B 10.53B 9.68B 8.77B 16.4B 1,116B 16.71B 115B 46.35B 587B 44.11B 43.17B P/E 2027 *
17.8x
P/E 2028 * 15.3x
Enterprise Value 1,935B 12.29B 11B 10.12B 9.17B 17.14B 1,167B 17.47B 121B 48.46B 614B 46.11B 45.13B EV / Sales 2027 *
1.79x
EV / Sales 2028 * 1.71x
Free-Float
94.58%
Yield 2027 *
1.76%
Yield 2028 * 1.84%
1 day-1.53%
1 week+1.34%
Current month-13.53%
1 month-13.53%
3 months-6.22%
6 months+12.64%
Current year-12.22%
1 week 1,707
Extreme 1707
1,785.5
1 month 1,668.5
Extreme 1668.5
2,048.5
Current year 1,302.5
Extreme 1302.5
2,210.5
1 year 1,302.5
Extreme 1302.5
2,210.5
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 64 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Director/Board Member 59 2021-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-1.53%+1.34%-8.65%-10.60% 11.75B
-1.72%+3.44%+25.31%+60.56% 258B
-2.00%+0.75%+7.99%+25.46% 163B
-3.73%-4.48%-18.49%+67.13% 150B
-1.66%-8.12%-58.26%-16.12% 60.84B
-2.57%+3.30%+10.22%+47.55% 53.03B
0.00%+2.46%-11.97%-6.29% 53.31B
-3.47%+1.04%+21.98%+72.85% 49.3B
+0.84%-3.12%+9.80%+64.47% 50.67B
-3.61%+1.99%+34.94%+95.49% 45.46B
Average -1.94%-0.14%+1.29%+40.05% 89.52B
Weighted average by Cap. -2.10%+0.17%+5.01%+47.03%

Financials

2027 *2028 *
Net sales 1,082B 6.87B 6.15B 5.66B 5.13B 9.59B 652B 9.77B 67.51B 27.1B 343B 25.79B 25.24B 1,123B 7.13B 6.38B 5.87B 5.32B 9.95B 677B 10.13B 70.03B 28.11B 356B 26.75B 26.18B
Net income 106B 670M 600M 552M 500M 935M 63.6B 952M 6.58B 2.64B 33.46B 2.51B 2.46B 122B 773M 692M 637M 577M 1.08B 73.39B 1.1B 7.59B 3.05B 38.6B 2.9B 2.84B
Net Debt 84.02B 533M 478M 439M 398M 744M 50.65B 758M 5.24B 2.1B 26.64B 2B 1.96B 65.49B 416M 372M 343M 310M 580M 39.48B 591M 4.08B 1.64B 20.77B 1.56B 1.53B
Projected Income Statement - Annual - Olympus Corporation
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-10-30 ¥1,742.00 -1.53% 4,914,900
26-10-29 ¥1,769.00 +0.91% 7,951,300
26-10-28 ¥1,753.00 +0.17% 4,176,600
26-10-27 ¥1,750.00 -0.09% 4,486,300
26-10-26 ¥1,751.50 +1.89% 6,169,700
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Olympus Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
1,742.00JPY
Average target price
2,084.62JPY
Spread / Average Target
+19.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Olympus Corporation
  1. Stock Market
  2. Stocks
  3. 7733 Stock